Article Information
History
- August 13, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Deja Edwards, MPH1,2,*,
- Pamela Logan, MD, MPH, MA2,
- Leora R. Feldstein, PhD, MSc2,
- Tarayn Fairlie, MD, MPH2,
- Emma Accorsi, PhD3,4 and
- Sharon Saydah, PhD2
- 1General Dynamics Information Technology (GDIT), Atlanta, GA 30361, USA
- 2Coronavirus & Other Respiratory Viruses Division (CORVD) National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), 1600 Clifton Rd., NE, Mailstop US1-1, Atlanta, GA 30329-4027, USA
- 3Respiratory Diseases Branch, Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), 1600 Clifton Rd., NE, Mailstop US1-1, Atlanta, GA 30329-4027, USA
- 4Epidemic Intelligence Service, Centers for Disease Control and Prevention (CDC), 1600 Clifton Rd., NE, Mailstop US1-1, Atlanta, GA 30329-4027, USA
- ↵* Corresponding author; email: pyd4{at}cdc.gov
Posted August 13, 2023.
Post-COVID conditions during Delta and early-Omicron SARS-CoV-2 variant periods among adults in the United States
